Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 10:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2689–2712 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Dental Plaque
Interventions: Negative Control (Regular Toothpaste), Positive Control (anti-plaque/anti-bacterial toothpaste), Prototype (AN0128 Toothpaste); Other · Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Cedar Knolls, New Jersey

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 45 Years to 80 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Coronary Artery Disease
Interventions: Cardiac Rehabilitation plus Transcendental Meditation; Behavioral
Lead sponsor: Maharishi International University; Other
Eligibility: Not listed
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Lupus Nephritis
Interventions: Guselkumab Dose 1, Placebo, Guselkumab Dose 2, Standard-of-care treatment; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 8
States / cities: Covina, California • La Jolla, California • Los Angeles, California + 5 more

Conditions: Neonatal Abstinence Syndrome, Vagal Tone
Interventions: Vagal tone assessment; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: Up to 1 Day
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Distal Radius Fracture, Rehabilitation
Interventions: occlusion training with tourniquet (DELFI PTS ii portable tourniquet system); Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Chronic Back Pain
Interventions: DTM Programming, Conventional SCS programming; Device
Lead sponsor: SGX Nova LLC; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Bloomington, Illinois

Conditions: Cytomegalovirus Retinitis, HIV Infections
Interventions: Nelfinavir mesylate; Drug
Lead sponsor: Agouron Pharmaceuticals; Industry
Eligibility: 13 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 8
States / cities: Los Angeles, California • Orange, California • San Diego, California + 5 more

Conditions: Catheter-related Bloodstream Infection (CRBSI) Nos, Bloodstream Infection Due to Central Venous Catheter, Bloodstream Infection Due to Hickman Catheter
Interventions: Ethanol, Heparin Lock, Normal Saline; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Smoking, Smoking Cessation, Smoking Reduction, Smoking Behaviors
Interventions: Reduction (relocation and reduction of personal smoking) and cessation, Resident Endorsement; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostatic Neoplasms, Prostate Cancer, Prostate Adenocarcinoma
Interventions: rhPSMA-7.3 (18F) PET/CT Imaging (Flotufolastat F18, POSLUMA®), Flotufolastat F18; Radiation · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Degenerative Joint Disease
Interventions: Steprite™, Standard of care; Device · Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: CGM + Family Behavioral Intervention, Standard CGM; Behavioral · Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 2 Years to 7 Years
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Acute Ischemic Stroke
Interventions: PP-007 (Two doses administered 24±6 hours apart) + SOC (IVT or MT or IVT+MT); Biological
Lead sponsor: Prolong Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Jacksonville, Florida • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Medication Abortion, Health Knowledge Attitudes and Practice, Pregnant People
Interventions: Patient Agreement Form (PAF); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 15 Years and older · Female only
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 5
States / cities: San Francisco, California • Denver, Colorado • Carbondale, Illinois + 2 more

Conditions: Breast Carcinoma, Head and Neck Carcinoma, Radiation-Induced Dermatitis
Interventions: Calendula Ointment, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Polyethylene Glycol Hydrogel, Silicone-based Film Forming Topical Gel, Silver Sulfadiazine, Topical Hydrocortisone; Drug · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Tibial Fractures, Pain
Interventions: 600 mg Ibuprofen; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 13
States / cities: Indianapolis, Indiana • Baltimore, Maryland • Cambridge, Massachusetts + 9 more

Conditions: Parkinson Disease
Interventions: Active NIR-PBM (MedX 1116, MCT502), Sham NIR-PBM (MedX 1116, MCT502); Device
Lead sponsor: University of Florida; Other
Eligibility: 62 Years to 89 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Prostate Cancer, Prostate Adenocarcinoma
Interventions: Radical Prostatectomy, TULSA Procedure; Device
Lead sponsor: Profound Medical Inc.; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2036
U.S. locations: 19
States / cities: Chandler, Arizona • Mesa, Arizona • Scottsdale, Arizona + 14 more

Conditions: Stage IV Breast Cancer AJCC v6 and v7
Interventions: Dietary Intervention, Laboratory Biomarker Analysis, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration; Dietary Supplement · Other · Drug
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Social Stress
Interventions: Screening survey and accompanying handout for resources; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 18 Years
Enrollment: 430 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome
Interventions: Nitric Oxide; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Shreveport, Louisiana • Boston, Massachusetts

Conditions: Post Operative, Post Operative Analgesia, Urogynecologic Surgery
Interventions: Tizanidine, Standard-of-Care Therapy; Drug · Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Alzheimer Disease, Dementia
Interventions: APPROACHES ACP Specialist Program, Standard of care; Behavioral · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 47,396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Warsaw, Indiana • Louisville, Kentucky

Search by objective public record fields.

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

Pathways Mediating Impaired Postural Control in Parkinson's Disease

A Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in Blacks

A Study of Guselkumab in Participants With Active Lupus Nephritis

Vagal Tone and Neonatal Abstinence Syndrome

BFR DISTRAD: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture Repair

SCS Programming Study in Treating Intractable Chronic Back Pain (NOVA)

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

Supporting Smoke-Free Policy Compliance in Public Housing

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

Comparative Effectiveness of an Activity-specific Monitoring Device- StepRite

Strategies to Enhance New CGM Use in Early Childhood (SENCE)

Safety Study of PP-007 in Subjects With Acute Ischemic Stroke

Patient Agreement Form and Medication Abortion Knowledge

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Revitalize Cognition: Near Infrared Stimulation in Parkinson Patients

A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer

Transforming Care and Payment Priorities for Vulnerable Families

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study

Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support